Literature DB >> 16537841

Is sustained pharmacologic lung volume reduction now possible in COPD?

Denis E O'Donnell.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 16537841     DOI： 10.1378/chest.129.3.501

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  4 in total

Review 1.  Outcome measures in chronic obstructive pulmonary disease (COPD): strengths and limitations.

Authors:  Thomas Glaab; Claus Vogelmeier; Roland Buhl
Journal:  Respir Res       Date:  2010-06-17

Review 2.  The safety of long-acting β2-agonists in the treatment of stable chronic obstructive pulmonary disease.

Authors:  Marc L Decramer; Nicola A Hanania; Jan O Lötvall; Barbara P Yawn
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2013-01-25

Review 3.  The role of bronchodilator treatment in the prevention of exacerbations of COPD.

Authors:  Jadwiga A Wedzicha; Marc Decramer; Terence A R Seemungal
Journal:  Eur Respir J       Date:  2012-07-26       Impact factor: 16.671

4.  Forced expiratory volumes in 3 s is a sensitive clinical measure for assessment of bronchodilator reversibility in elderly Chinese with severe lung function impairment.

Authors:  Mingming Pan; Hongsheng Zhang; Tieying Sun
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-08-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.